Program for the 5^th Annual WASOG Conference on Diffuse Lung Diseases, March 25-27, 2009
Wild Dunes Resort, Charleston, South Carolina, USA

Wednesday March 25, 2009 - Catherine Gaisman Day

8:30 a.m. Welcome: Marc A. Judson, M.D.

Session 1: Evidenced-based management of ILD’s. Proposals of management algorithms of ILD’s based upon clinical data.
Session Co-Chairs: Kevin K. Brown, MD and Harold R. Collard, MD
     8:40 a.m. Idiopathic Pulmonary Fibrosis: Harold R. Collard, MD
     9:05 a.m. Nonspecific Interstitial Pneumonitis secondary to CVD: Kevin Brown, MD
     9:30 a.m. Sarcoidosis: Robert Baughman. MD

9:55 Break

Session 2: Scleroderma symposium
Session Co-Chairs: Charlie Strange, MD and Richard M. Silver, MD
     10:15 a.m. Pathogenesis of Scleroderma and Scleroderma Interstitial Lung Disease: Richard Silver. MD
     10:40 a.m. The Treatment of Scleroderma: Charlie Strange, MD
     11:05a.m.: Pulmonary Hypertension in Scleroderma: Krisitin Highland, MD
     11:30 a.m. Q + A

12:00 p.m. Lunch (provided)

Session 3: Health Related Quality of Life in Interstitial Lung Diseases 
Session Chair: Marjolein Drent, MD, PhD
     1:00 p.m. Health Related Quality of Life in Interstitial Lung Diseases: Why we Should Measure it. How Should we Measure it? Marc Judson, MD 
     1:25 p.m. Health Related Quality of Life in Idiopathic Pulmonary Fibrosis: Violeta Vucinic, MD
     1:50 p.m. The Impact of Sarcoidosis on the Patient's Life: Marjolein Drent, MD

2:15 p.m. Break

Session 4: Genetics in Interstitial Lung Disease
Session Chair: Imre Noth, MD
     2:35 p.m. Idiopathic Pulmonary Fibrosis: Imre Noth, MD
     3:00 p.m. Sarcoidosis: Professor Dr. J. Müller-Quernheim
     3:25 p.m. Familial Interstitial Lung Disease: Mark Steele, MD

3:50 p.m.  Break

Session 5: Miscellaneous Mini-sessions
Session Co-Chairs: Martin Petrek, MD, PhD and Gianpietro Semenzato, MD
     4:00 p.m. The Treatment of Idiopathic Pulmonary Fibrosis with Pirfenidone: Arata Azuma, MD
     4:10 pm. Bronchoscopic Findings in Wegener’s Granulomatosis: Vlasis S. Polychronopoulos, MD
     4:20 p.m. Oxidative Stress and Lung Disease: TBA

4:30 p.m. Abstract Sessions (60 minutes)
Session Chairs: Om. Sharma, MD; Robert Baughman, MD; Arata Azauma, MD; Vlasis S. Polychronopoulos, MD

• Idiopathic pulmonary fibrosis
• Interstitial lung disease secondary to collagen vascular diseases
• Sarcoidosis *
• Pulmonary vasculitis
• Hypersensitivity pneumonitis
• Genetics

7:00 p.m. Welcome Dinner

Thursday March 26, 2009

Session 6: Pulmonary Hypertension in Interstitial Lung Disease
Session Chair: Kristin B. Highland, MD
     8:00 a.m. Sarcoidosis: Peter Engel, MD
     8:25 a.m. Idiopathic Pulmonary Fibrosis: David Zisman, MD
     8:50 a.m. Interstitial Lung Disease Related to Collagen Vascular Disease: Kristin Highland, MD

9:15 a.m. Break

Session 7: The diagnosis of Interstitial Lung Disease 
Session Co-Chairs: Ulrich Costabel, MD and F. Martinez, MD
       9:35 a.m. The Use of High Resolution CT Scanning in the Diagnosis of Interstitial Lung Disease: David Lynch, MD
     10:00 a.m. The Use of Bronchoalveolar Lavage in the Diagnosis of Interstitial Lung Disease: Ulrich Costabel, MD
     10:25 a.m. The Use of Pathology in the Diagnosis of Interstitial Lung Disease: Kevin O. Leslie, MD
     10:50 a.m. How to Use Clinical Data in Conjunction with Laboratory Tests to Make a Diagnosis of Interstitial Lung Disease: Ganesh Raghu, MD
     11:15 a.m. Q + A

12:00 p.m. Lunch (provided)

Session 8: Mechanisms of Interstitial Lung Disease 
Session Co-Chairs: Moises Selman, MD and Paola Rattoli, MD
     1:00 p.m. Overview of pathogenic mechanisms in Idiopathic Pulmonary Fibrosis: Moises Selman, MD
     1:25 p.m. Proteomics: Paola Rotolli, MD
     1:50 p.m. Genetics: Martin Petrak, MD
     2:15 p.m. The Role of Metalloproteinases in the Development of Lung Fibrosis: Annie Pardo, MD

2:40 Break

Session 9: Wegener’s Granulomatosis and Related Pulmonary Vasculitis Syndromes
Session Co-Chairs: Ulrich Specks, MD and Vlasis S. Polychronopoulos, MD
     3:05 p.m. Update on Clinical Management of Wegener's Granulomatosis and Microscopic Polyangiitis: Ulrich Specks, MD
     3:30 p.m.  Tracheobronchial Manifestations of Wegener's Granulomatosis: the Interventional Bronchoscopist's Perspective: Eric S. Edell, MD
     3:55 p.m. Update on the Churg-Strauss Syndrome: Karina Keogh, MD

4:20 p.m. Abstract Sessions (70 minutes)
Session Chairs: Mani S. Kavuru, MD; Johan Grunewald, MD, PhD; Ulrich Costabel, MD; Professor Dr. Joachim Muller-Quernheim; Ulrich Specks, MD

• Bronchoalveolar lavage
• Health related quality of life
• Pulmonary hypertension
• Immunology
• Case reports
• Miscellaneous

Friday March 27th

Session 10:  The Robert J. Isakson Sarcoidosis Symposium
Session Chairs: Om Sharma, MD; Johan Grunewald, MD, PhD; Robert Baughman, MD
     9:00 a.m. What has Chronic Beryllium Disease Taught Us About Sarcoidosis?: Andrew Fontenot, MD
     9:30 a.m. Review of Biomarkers in Sarcoidosis: Linda Efferen, MD
     10:00 a.m. Potential Future Therapies for Sarcoidosis: Robert Baughman, MD

10:30 a.m. Break

     10:50 a.m. HLA and sarcoidosis: Johan Grunewald, MD
     11:20 a.m. The Diagnosis of Sarcoidosis: Marc Judson, MD
     11:50 a.m. Conference summary

Charleston Pulmonary Symposium

Friday March 27, 2009 - Sunday, March 29, 2009